Copeland Capital Management, LLC Novozymes A/S Sponsored Adr (D Transaction History
Copeland Capital Management, LLC
- $5.61 Billion
- Q3 2024
A detailed history of Copeland Capital Management, LLC transactions in Novozymes A/S Sponsored Adr (D stock. As of the latest transaction made, Copeland Capital Management, LLC holds 45 shares of NVZMY stock, worth $2,546. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$2,546% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding NVZMY
# of Institutions
11Shares Held
35.4KCall Options Held
0Put Options Held
0-
Rhumbline Advisers Boston, MA10.2KShares$575,8590.0% of portfolio
-
Sterling Capital Management LLC Charlotte, NC7.27KShares$411,1820.01% of portfolio
-
Gofen & Glossberg LLC5KShares$282,9500.01% of portfolio
-
S&Co Inc Boston, MA4.5KShares$254,6550.02% of portfolio
-
Boston Common Asset Management, LLC Boston, MA4.12KShares$233,0940.01% of portfolio
About NOVOZYMES A/S SPONSORED ADR (D
- Ticker NVZMY
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 276,303,008
- Market Cap $15.6B